Related Experiment Video
Updated: May 10, 2025

08:47
Endoscopic Cholesteatoma Surgery
Published on: January 19, 2022
9.6K
Rigid Autofluorescence Imaging as a Tool for Identifying Cholesteatoma During Otologic Surgery: Initial Ex Vivo
Hylke F E van der Toom1, Henriette S de Bruijn1,2, Robert Jan Pauw1
1Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Summary
Rigid autofluorescence imaging effectively distinguishes cholesteatoma from surrounding mucosa, showing significantly higher signal intensities. This technique aids surgeons in achieving complete cholesteatoma removal and reducing residual disease.
Area of Science:
- Otolaryngology
- Medical Imaging
- Surgical Technology
Background:
- Cholesteatoma surgery aims for complete removal to prevent recurrence.
- Residual cholesteatoma disease remains a significant clinical challenge.
- Differentiating cholesteatoma from healthy tissue intraoperatively can be difficult.
Purpose of the Study:
- To evaluate rigid autofluorescence imaging for differentiating cholesteatoma from surrounding tissues.
- To assess the potential of this technique in reducing residual disease after cholesteatoma surgery.
Main Methods:
- An ex vivo proof-of-principle study was conducted.
- Autofluorescence signals of cholesteatoma and mucosa were measured using confocal microscopy.
- Rigid autofluorescence imaging with specific filter settings was applied to 14 surgical specimens.
Main Results:
- Cholesteatoma matrix (with and without keratin) showed significantly higher autofluorescence intensity compared to mucosa (ratios of 2.15-2.29).
- Perimatrix with keratin also exhibited elevated autofluorescence.
- No significant difference was observed between cholesteatoma and bone, which is clinically manageable.
Conclusions:
- Rigid autofluorescence imaging reliably differentiates cholesteatoma matrix from mucosa.
- The technique offers potential for more complete cholesteatoma resections and reduced residual disease.
- Further research is needed for in vivo application and optimization for detecting small cholesteatoma fragments.

